Page last updated: 2024-09-04

aclacinomycin and Leukemia P388

aclacinomycin has been researched along with Leukemia P388 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dong, J; Johdo, O; Naito, M; Seimiya, H; Tatsuta, T; Tsuruo, T	1

Other Studies

1 other study(ies) available for aclacinomycin and Leukemia P388

Article	Year
Difference between the resistance mechanisms of aclacinomycin- and adriamycin-resistant P388 cell lines. Oncology research, 1995, Volume: 7, Issue:5 Topics: Aclarubicin; Animals; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Nucleus; DNA Topoisomerases, Type II; DNA, Neoplasm; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Humans; Immunoblotting; Leukemia P388; Tumor Cells, Cultured; Verapamil; Vincristine	1995

Article

Year

Difference between the resistance mechanisms of aclacinomycin- and adriamycin-resistant P388 cell lines.

Oncology research, 1995, Volume: 7, Issue:5

Topics: Aclarubicin; Animals; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Nucleus; DNA Topoisomerases, Type II; DNA, Neoplasm; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Humans; Immunoblotting; Leukemia P388; Tumor Cells, Cultured; Verapamil; Vincristine

1995